Logo image of EDTX

EdtechX Holdings Acquisition Corporation II (EDTX) Stock Fundamental Analysis

NASDAQ:EDTX - Nasdaq - US28139A1025 - Common Stock - Currency: USD

63.24  +20.01 (+46.29%)

After market: 36.4 -26.84 (-42.44%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to EDTX. EDTX was compared to 0 industry peers in the Unkown industry. The financial health of EDTX is average, but there are quite some concerns on its profitability. EDTX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year EDTX was profitable.
In the past year EDTX has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: EDTX reported negative net income in multiple years.
EDTX had a negative operating cash flow in each of the past 5 years.
EDTX Yearly Net Income VS EBIT VS OCF VS FCFEDTX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 0 2M 4M

1.2 Ratios

Industry RankSector Rank
ROA 23.11%
ROE 44.27%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EDTX Yearly ROA, ROE, ROICEDTX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 0 20 -20 -40

1.3 Margins

EDTX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EDTX Yearly Profit, Operating, Gross MarginsEDTX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022

More info and screens

5

2. Health

2.1 Basic Checks

EDTX has less shares outstanding than it did 1 year ago.
Compared to 1 year ago, EDTX has a worse debt to assets ratio.
EDTX Yearly Shares OutstandingEDTX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 5M 10M
EDTX Yearly Total Debt VS Total AssetsEDTX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 76.11 indicates that EDTX is not in any danger for bankruptcy at the moment.
EDTX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 76.11
ROIC/WACCN/A
WACCN/A
EDTX Yearly LT Debt VS Equity VS FCFEDTX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 0 20M 40M 60M 80M 100M

2.3 Liquidity

EDTX has a Current Ratio of 0.20. This is a bad value and indicates that EDTX is not financially healthy enough and could expect problems in meeting its short term obligations.
EDTX has a Quick Ratio of 0.20. This is a bad value and indicates that EDTX is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.2
Quick Ratio 0.2
EDTX Yearly Current Assets VS Current LiabilitesEDTX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 200K 400K 600K 800K

More info and screens

0

3. Growth

3.1 Past

EDTX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -45.23%.
EPS 1Y (TTM)-45.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-99.91%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

EDTX is valuated quite expensively with a Price/Earnings ratio of 527.00.
The average S&P500 Price/Earnings ratio is at 28.22. EDTX is valued rather expensively when compared to this.
Industry RankSector Rank
PE 527
Fwd PE N/A
EDTX Price Earnings VS Forward Price EarningsEDTX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EDTX Per share dataEDTX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

EDTX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EdtechX Holdings Acquisition Corporation II

NASDAQ:EDTX (7/14/2023, 8:00:02 PM)

After market: 36.4 -26.84 (-42.44%)

63.24

+20.01 (+46.29%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-26 2023-05-26
Earnings (Next)08-30 2023-08-30
Inst Owners3.8%
Inst Owner Change0%
Ins Owners24.96%
Ins Owner Change0%
Market Cap199.19M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 527
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 119.08
P/tB 119.08
EV/EBITDA N/A
EPS(TTM)0.12
EY0.19%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.35
FCFYN/A
OCF(TTM)-0.35
OCFYN/A
SpS0
BVpS0.53
TBVpS0.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 23.11%
ROE 44.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.2
Quick Ratio 0.2
Altman-Z 76.11
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-45.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-99.91%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-10.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-140.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-140.84%
OCF growth 3YN/A
OCF growth 5YN/A